SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-16-426184
Filing Date
2016-01-11
Accepted
2016-01-11 13:15:59
Documents
3
Group Members
COLUMBIA MANAGEMENT INVESTMENT ADVISERS, LLCCOLUMBIA SELECT LARGE CAP GROWTH FUND

Document Format Files

Seq Description Document Type Size
1 SC 13G d117509dsc13g.htm SC 13G 60625
2 EX-99.1 d117509dex991.htm EX-99.1 1067
3 EX-99.2 d117509dex992.htm EX-99.2 4697
  Complete submission text file 0001193125-16-426184.txt   68390
Mailing Address 1099 AMERIPRISE FINANCIAL CENTER MINNEAPOLIS MN 55474
Business Address 1099 AMERIPRISE FINANCIAL CENTER MINNEAPOLIS MN 55474 612-671-3131
AMERIPRISE FINANCIAL INC (Filed by) CIK: 0000820027 (see all company filings)

IRS No.: 133180631 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6282 Investment Advice

Mailing Address 450 W. 15TH STREET SUITE 505 New York NY 10011
Business Address 450 W. 15TH STREET SUITE 505 NEW YORK NY 10011 646-747-1000
INTERCEPT PHARMACEUTICALS INC (Subject) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87033 | Film No.: 161335843
SIC: 2834 Pharmaceutical Preparations